Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Heidelberg University is a comprehensive university with a strong focus on research and international standards. With around 31,300 students and 8,400 employees, including numerous top researchers
-
culture and molecular biology techniques. The project also comprises a substantial amount of in vivo work, which will be performed in collaboration with experienced senior researchers. Therefore, a strong
-
data integration, cancer systems biology, and single-cell analysis, with strong links to clinical and translational oncology. Our work is based in the dynamic research environment of Heidelberg
-
, RNA biology, and stem cell research Bioinformatics experience, e.g. R, preferred High motivation, curiosity, and the ability to work independently and in a team as well as good communication skills in
-
the possibility for extension) Contract:TV-L Your tasks We are looking for motivated researcher with experience in mass spectrometry-based proteomics to join a project aimed at understanding cellular plasticity
-
assays to assess for intercellular interaction and migration, CRISPR-based perturbation-of-adhesion and synthetic lethality screening, drug synergy assays, and others. The PhD student will work closely
-
chemistry) We offer an international and attractive work environment in Heidelberg (research group Mastalerz). The salary is based on TV-L scale (E13). The position is limited to two years, with
-
functional cell assays Interest in translational leukemia research and innovative imaging and omics technologies Bioinformatics experience, especially in R Ideally initial experience with image analysis, laser
-
to understand the role of microbiota in the development and therapy response of PDAC. We work in a highly motivated and international team in close collaboration with our colleagues at the German Cancer research
-
soon as possible at Department of Cardiology, Angiology and Pneumology. The research group "Molecular and Translational Cardiology", headed by Prof. Dr. Patrick Most and Dr. Julia Ritterhoff, focuses